MENU
+Compare
NUMIF
Stock ticker: OTC
AS OF
Jan 14 closing price
Price
$0.04
Change
+$0.01 (+33.33%)
Capitalization
12.79M

NUMIF Numinus Wellness Inc. Forecast, Technical & Fundamental Analysis

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes... Show more

NUMIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NUMIF with price predictions
Jan 13, 2026

NUMIF's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NUMIF turned positive on January 02, 2026. Looking at past instances where NUMIF's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where NUMIF advanced for three days, in of 184 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on January 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NUMIF as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NUMIF moved below its 50-day moving average on January 13, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUMIF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUMIF broke above its upper Bollinger Band on January 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NUMIF entered a downward trend on January 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NUMIF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.921) is normal, around the industry mean (8.038). P/E Ratio (0.000) is within average values for comparable stocks, (114.199). NUMIF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.902). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (2.697) is also within normal values, averaging (1.383).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUMIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
NUMIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
N/A
Address
801 - 33 Water Street
Phone
+1 883 686-4687
Employees
200
Web
https://www.numinus.ca
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HDL16.250.30
+1.88%
Super Hi International Holding Ltd ADR
HESM34.930.20
+0.58%
Hess Midstream LP
ELWS6.06-0.02
-0.33%
Earlyworks Co Ltd.
DDOG122.41-3.09
-2.46%
Datadog
CHRS1.60-0.10
-5.88%
Coherus Oncology Inc

NUMIF and Stocks

Correlation & Price change

A.I.dvisor tells us that NUMIF and PHCI have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUMIF and PHCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUMIF
1D Price
Change %
NUMIF100%
+23.53%
PHCI - NUMIF
11%
Poorly correlated
N/A
PIII - NUMIF
9%
Poorly correlated
-1.97%
DCGO - NUMIF
8%
Poorly correlated
-2.95%
BDULF - NUMIF
7%
Poorly correlated
N/A
AIRS - NUMIF
6%
Poorly correlated
-4.00%
More

Groups containing NUMIF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUMIF
1D Price
Change %
NUMIF100%
+23.53%
Hospital/Nursing Management
industry (87 stocks)
-2%
Poorly correlated
+0.06%